南京吉迈生物技术

Nanjing Jimai Biotechnology is a high-tech enterprise specializing in the development and commercialization of digital PCR (dPCR) systems and molecular diagnostic reagents. The company provides integrated solutions for precision medicine, focusing on oncology, infectious disease detection, and reproductive health. Their core technology platform enables absolute quantification of nucleic acids with high sensitivity and precision, which is critical for liquid biopsy and rare mutation detection. Jimai Biotechnology's product portfolio includes dPCR instruments, automated sample processing systems, and a variety of detection kits for clinical and research applications. The company aims to bridge the gap between advanced molecular biology research and clinical diagnostic needs through innovative engineering and biochemical solutions.